Cali Biosciences
PrivateLast Round
Series B
Jun 13, 2023
Est. Valuation
$237.32M
Total Funding Raised
$81.94M
Company Overview
Cali Biosciences operates in Healthcare & Life Sciences and is based in Shenzhen. Its latest recorded funding round was a Series B round in June 2023.
Cali Biosciences is a biopharmaceutical company that develops innovative drug delivery platforms and perioperative medications, including anesthesia, analgesia, and anti-inflammatory treatments.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Cali Biosciences Comparables
Compare Cali Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| PRF Technologies Ltd. | 81% | |
| Allay Therapeutics | 81% | |
| Concentric Analgesics | 79% |
For institutional investors. Book with your work email.
Cali Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jun 13, 2023 | ||||
| Series A | Oct 15, 2021 | ||||
| Early Funding | Jun 4, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Cali Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Shenzhen Qianhai Bangqin Investment | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 19, 2026
Monthly visitors increased 641% MoM, from 54 to 400.
- Oct 15, 2021
$16M round closed
For institutional investors. Book with your work email.
Cali Biosciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Cali Biosciences's valuation, stock price, and market status.
Is Cali Biosciences a public or private company?
Cali Biosciences is a private company.
What is the current stock price of Cali Biosciences?
Cali Biosciences is a private company, so its shares have no public market price. Caplight tracks Cali Biosciences's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Cali Biosciences worth (valuation)?
Cali Biosciences's valuation is estimated at $237.3M based on funding round data.
Can I buy Cali Biosciences stock?
Cali Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Cali Biosciences's last funding round?
Cali Biosciences's most recent funding round was Series B on June 13, 2023.
Who are the main investors in Cali Biosciences?
Key investors in Cali Biosciences include Shenzhen Qianhai Bangqin Investment.
Will Cali Biosciences IPO soon?
No public IPO plans have been announced for Cali Biosciences.
How can I track Cali Biosciences secondary market activity?
Caplight tracks bids, offers, and trades in Cali Biosciences's shares on secondary markets.